OTCMKTS:BIOTU Biotech Acquisition (BIOTU) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free BIOTU Stock Alerts $10.14 -0.84 (-7.65%) (As of 02/2/2023) Add Compare Share Share Today's Range$10.14▼$10.1750-Day Range$10.14▼$10.1452-Week Range$8.73▼$11.11Volume1,300 shsAverage Volume4,444 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Biotech Acquisition alerts: Email Address Ad DTIBuy Friday, Sell Monday, No Exceptions Every week traders grind it out Monday through Friday… But neglect trading Friday to Monday… Or… “over the weekend” As one professional trader explains, trading over the weekend is one of the most forgiving strategies you can use today. It allows him to sidestep a lot of the midweek volatility. Yet, gives him the opportunity to target some of the markets biggest stock moves. Just recently, he posted a trade on Nordstrom… The trade was published at 3pm on a Friday afternoon and by Monday morning the trade more than doubled.And for the first time in 2024, he’s sharing his strategy for free. About Biotech Acquisition Stock (OTCMKTS:BIOTU)Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.Read More BIOTU Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BIOTU Stock News HeadlinesMarch 21, 2024 | msn.comEXCLUSIVE: 2024 Witnesses Increase In Biotech Initial Public OfferingsFebruary 23, 2024 | msn.com20 Fastest Growing Biotech Companies in the USMarch 28, 2024 | Crypto Swap Profits (Ad)Did You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.February 19, 2024 | msn.comAstra Boosts Push Into China Biotech Scene With $1.2 Billion BuyFebruary 18, 2024 | finance.yahoo.comCERo Therapeutics Holdings Inc (CERO)February 7, 2024 | msn.comPhoenix Biotech Revises CERo Agreement and PIPE DealFebruary 7, 2024 | msn.comPhoenix Biotech’s Strategic Unregistered Equity SaleFebruary 5, 2024 | bizjournals.comHere's what could turn around Massachusetts' biotech job market in 2024March 28, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…January 12, 2024 | realmoney.thestreet.com4 Biotech Stock Moves I Made Amid a Bullish Call on the SectorJanuary 8, 2024 | msn.comPhilly biotech execs find ‘optimistic vibe’ at invitation-only JPM Healthcare ConferenceJanuary 5, 2024 | msn.com3 Top Biotech Stocks Worth Adding to Your Portfolio in 2024January 4, 2024 | seekingalpha.comBiotech Bonanza: 2024 Biotech Outlook As The Fed Turns DovishJanuary 2, 2024 | msn.comGene-editing startup Tome Biosciences of Watertown snaps up a San Francisco biotechDecember 14, 2023 | msn.comWhat Has Insiders Eyeing This Biotech StockDecember 8, 2023 | msn.comBiotech Deals Are Heating Up. Why 2024 Could Be Even Hotter for M&A.November 16, 2023 | msn.comFortress Biotech GAAP EPS of -$0.94 beats by $1.83, revenue of $34.75M beats by $16MNovember 9, 2023 | msn.comAdaptive Biotech hires Goldman Sachs to explore ‘strategic alternatives’ for key business linesNovember 1, 2023 | bizjournals.comBiotech company led by former Seagen CEO picks Eastside city for new HQOctober 19, 2023 | reuters.comRisky biotech M&A therapy will heal more fracturesSeptember 27, 2023 | markets.businessinsider.com7 ‘Strong Buy’ Biotech Stocks to Rejuvenate Your PortfolioSeptember 5, 2023 | marketwatch.comPortage Biotech Shares Rise 20% After Keytruda Deal With MerckAugust 17, 2023 | msn.com7 A-Rated Biotech Stocks for Your August Buy ListJuly 27, 2023 | msn.comBharat Biotech picks up 20% stake in Eastman Exports Global ClothingJuly 21, 2023 | marketwatch.comBB Biotech 2Q Loss Narrowed; To Delist From Milan Stock ExchangeJuly 20, 2023 | msn.comThe 3 Most Undervalued Biotech Stocks to Buy Now: July 2023July 14, 2023 | markets.businessinsider.comThese 2 Biotech Stocks Are Most Likely to Be Acquired, Says Needham — Here’s How Much They Could Be Acquired ForSee More Headlines Receive BIOTU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorFinancial Services Industry Shell Companies Sub-IndustryN/A Current SymbolOTCMKTS:BIOTU CUSIPN/A CIK1825413 WebN/A PhoneN/AFaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Michael Shleifer Ph.D. (Age 49)Chairman & CEO Mr. Thomas Fratacci (Age 45)CFO & Treasurer Mr. Ivan Jarry (Age 45)Chief Operating Officer Mr. Albert F. Hummel M.B.A. (Age 77)Chief Investment Officer & Director Key Competitors99 Acquisition GroupNASDAQ:NNAGU99 Acquisition GroupNASDAQ:NNAGWA SPAC I AcquisitionNASDAQ:ASCAUA SPAC I AcquisitionNASDAQ:ASCAWA SPAC II AcquisitionNASDAQ:ASCBUView All Competitors BIOTU Stock Analysis - Frequently Asked Questions How have BIOTU shares performed in 2024? Biotech Acquisition's stock was trading at $10.14 at the beginning of 2024. Since then, BIOTU shares have increased by 0.0% and is now trading at $10.14. View the best growth stocks for 2024 here. How do I buy shares of Biotech Acquisition? Shares of BIOTU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BIOTU) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford ClubFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotech Acquisition Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.